Reply to N.F. Saba and S.J. Wong.

@article{Harrington2016ReplyTN,
  title={Reply to N.F. Saba and S.J. Wong.},
  author={Kevin J. Harrington and Jean P Bourhis},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2016},
  volume={34 17},
  pages={
          2073-4
        }
}
In response to our recent report, Saba and Wong make a number of important observations regarding the potential role for dual epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor 2 (HER2) –targeted therapy as part of combined chemoradiotherapy in patients with squamous cell carcinoma of the head and neck (SCCHN). They question the potential influence of human papillomavirus (HPV) –positive oropharyngeal squamous cell carcinoma on the overall study results, pointing out… CONTINUE READING